All three methylation clocks move in the same direction. Young hearts in old hosts read older than isochronic controls; old hearts in young hosts read younger. At the CpG level, methylation changes in young grafts correlate positively with normal aging, and the correlation flips sign for old grafts. The transcriptomic signatures agree. Three independent readouts pointing one way is the best thing in the paper.

Group sizes are four to six. The unsupervised analysis found no age separation among grafts at all, which the authors acknowledge; the signal appears only through clocks trained to find it. Transplantation itself raised clock age in every graft, so the comparison is relative to other transplanted hearts. A heart in the neck is perfused but does not pump against a load, and it has no innervation. "Rejuvenated" here means a clock reading, with no mouse function data.

Native hearts, livers, and blood showed no consistent clock shift. The authors contrast this with their parabiosis work, where age traded in both directions.

This is an absence of effect in five mice per group, which is not the same as evidence of no effect. It also sits uneasily beside the Tullius group's own 2023 paper, in which old organs promoted senescence in young recipients. One organ against a whole body is a lopsided dose, so the result is plausible. It is not demonstrated.

In eleven archived biopsies, Horvath's original clock separated old to young from young to old transplants, and clock age correlated with recipient age. Universal Clock 3 agreed.

Universal Clock 2 did not reach significance. The samples were formalin fixed and paraffin embedded, which the authors concede is not ideal for methylation work. The bigger problem is what a biopsy contains. Endomyocardial biopsies are taken to look for rejection. Bulk tissue from a transplanted heart includes recipient derived immune cells and, to a debated degree, recipient derived vascular cells. Those cells carry the recipient's methylation age. A graft can appear to take on the host's age partly because it contains some of the host. The paper does not address cell composition in the text I read. (The best known paper on cardiac chimerism, Quaini 2002, now carries an NEJM expression of concern, so the size of that effect in human hearts is itself unsettled.)

In several hundred recipients, older recipient age predicted lower VO2 max and functional capacity at one year, after adjusting for donor age and sex, and survived adjustment for BMI. Heart rate and posterior wall thickness also tracked recipient age. Ejection fraction, QTc, septal thickness, and ventilatory efficiency did not.

Exercise capacity after transplant is set largely by the person attached to the heart. Skeletal muscle, deconditioning, steroid exposure, and the blunted heart rate response of a denervated graft all get worse with age. A 65 year old recipient would be expected to have a lower VO2 max than a 30 year old with any heart. Posterior wall thickness is plausibly hypertension, which is common after calcineurin inhibitors. The figure title says outcomes track recipient "but not donor" age, but the text reports only the recipient coefficients. This is the paper's weakest link, and it is presented as the strongest validation.

The discussion is careful. It says the finding "raises the possibility" and that research is needed on whether lower graft biological age yields comparable outcomes. Registry data give the idea some room. In the OPTN database (2006 to 2024, 39,868 transplants), old donor into young recipient was not associated with excess mortality, while old into old was (HR 1.64).

The abstract is less careful, closing on rejuvenation and "novel approaches to organ allocation." A UNOS analysis the authors cite found donors 45 and older associated with higher one and three year mortality and graft failure. Registry pairings are chosen by surgeons, so neither study isolates the effect. Their own data stop at one year and do not touch allograft vasculopathy or death. In kidney allocation, donor age sits inside the KDPI because older kidneys fail sooner in any recipient. A methylation clock reading younger has not yet been shown to change that arithmetic.